DocGo Inc. (NASDAQ:DCGO) Receives $3.56 Consensus Price Target from Brokerages

DocGo Inc. (NASDAQ:DCGO) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $3.56.

Several brokerages recently issued reports on DCGO. Needham & Company LLC decreased their target price on DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a research note on Friday, May 9th. Canaccord Genuity Group reissued a “hold” rating and set a $1.45 target price (down previously from $5.00) on shares of DocGo in a research note on Monday, May 12th. Finally, BTIG Research downgraded DocGo from a “buy” rating to a “neutral” rating in a research note on Friday, May 9th.

DocGo Stock Up 1.0%

Shares of DocGo stock opened at $1.59 on Thursday. The business has a 50 day moving average of $1.64 and a 200 day moving average of $2.98. DocGo has a 52 week low of $1.23 and a 52 week high of $5.68. The company has a market cap of $161.64 million, a PE ratio of -79.25 and a beta of 0.97.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The company had revenue of $96.03 million during the quarter, compared to the consensus estimate of $104.25 million. DocGo had a positive return on equity of 2.52% and a negative net margin of 0.12%. On average, research analysts anticipate that DocGo will post 0.25 earnings per share for the current year.

Institutional Trading of DocGo

A number of large investors have recently added to or reduced their stakes in DCGO. Rhumbline Advisers increased its stake in DocGo by 4.5% in the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock worth $605,000 after acquiring an additional 6,204 shares during the last quarter. Bank of New York Mellon Corp increased its stake in DocGo by 25.6% in the 4th quarter. Bank of New York Mellon Corp now owns 338,159 shares of the company’s stock worth $1,434,000 after acquiring an additional 69,007 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of DocGo by 12.3% in the 4th quarter. Victory Capital Management Inc. now owns 57,649 shares of the company’s stock worth $244,000 after purchasing an additional 6,300 shares during the period. Raymond James Financial Inc. purchased a new position in shares of DocGo in the 4th quarter worth approximately $527,000. Finally, First Eagle Investment Management LLC purchased a new position in shares of DocGo in the 4th quarter worth approximately $1,116,000. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.